32
Informaciones
Psiquiátricas
2017 - n.º 228
treatment of major depressive disorder.
Expert Opin Pharmacother. 2014 Jul;
15(10):1449-63.
13. Ferguson J, Tourian KA, Manley AL, Pad-
manabhan SK, Nichols A. An Evaluation
of the Efficacy, Safety, and Tolerabili-
ty of Desvenlafaxine in the Long-term
Treatment of Elderly Outpatients With
Major Depressive Disorder. Primary
Psychiatry. 2010; 17(1):66-73.
14. McEwen BS, Chattarji S, Diamond DM,
Jay TM, Reagan LP, Svenningsson P, Fu-
chs E. The neurobiological properties of
tianeptine (Stablon): from monoamine
hypothesis to glutamatergic modulation.
Mol Psychiatry. 2010 Mar; 15(3):237-49.
15. Saiz-Ruiz J, Montes JM, Alvarez E, Cer-
vera S, Giner J, Guerrero J, Seva A, Dou-
rdil F, López-Ibor JJ. Tianeptine thera-
py for depression in the elderly. Prog
Neuropsychopharmacol Biol Psychiatry.
1998 Feb ;22(2):319-29.
16. Sanchez C, Asin KE, Artigas F. Vortioxe-
tine, a novel antidepressant with multi-
modal activity: review of preclinical and
clinical data. Pharmacol Ther. 2015 Jan;
145:43-57.
17. Katona C, Hansen T, Olsen CK. A rando-
mized, double-blind, placebo contro-
lled, duloxetine-referenced, fixed-dose
study comparing the efficacy and sa-
fety of Lu AA21004 in elderly patients
with major depressive disorder. Int Clin
Psychopharmacol. 2012 Jul; 27(4):215-
23.
18. Geduldig ET, Kellner CH. Electroconvulsi-
ve Therapy in the Elderly: New Findings
in Geriatric Depression. Curr Psychiatry
Rep. 2016 Apr; 18(4):40.
19. Kumar S, Mulsant BH, Liu AY, Blumberger
DM, Daskalakis ZJ, Rajji TK. Systematic
Review of Cognitive Effects of Electro-
convulsive Therapy in Late Life Depres-
sion. Am J Geriatr Psychiatry. 2016 Jul;
24(7):547-65.
Virginia Soria
